MUMBAI, Sept 30 Private equity firms Carlyle
Group and 3i (III.L) are among those holding preliminary
discussions to take a minority stake in India's Strides
Arcolab's (STAR.BO) injectables business, the Economic Times
reported on Wednesday, citing banking sources.
The Indian drug maker has hired investment bank Lazard
(LAZ.N) and expects to raise between $170 million to $200
million, the newspaper said.
A company official was unwilling to offer any comment on
the development, it said.
Officials at Carlyle, 3i and Strides could not be
immediately reached by Reuters.
(Reporting by Narayanan Somasundaram; Editing by Ranjit